Mapping the terrain of investment in global infectious diseases

The Lancet Infectious Diseases

Volumn 13, Issue 1, 2013, Pages 6-7

  Kyratsis, Yiannis ^a   Ahmad, Raheelah ^a,b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FUNDING; HEALTH STATUS; HUMAN; HUMAN NEEDS; INFECTION; LETTER; MEDICAL RESEARCH; PRIORITY JOURNAL; PUBLIC NEED;

BIOMEDICAL RESEARCH; COMMUNICABLE DISEASES; HUMANS; RESOURCE ALLOCATION;

EID: 84871093578     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(12)70289-X     Document Type: Letter

References (11)

1. Sridhar D Who sets the global health research agenda? The challenge of multi-bi financing. PLoS Med 2012, 9:e1001312.
2. Moran M, Guzman J, Ropars A-L, et al. Neglected disease research and development: how much are we really spending?. PLoS Med 2009, 6:e1000030.
3. Moran M, Guzman J, Henderson K, et al. G-FINDER 2009. Neglected disease research & development: new time, new trends? 2009, The George Institute for International Health, Sydney.
4. Ernst K, Irwin R, Galsworthy M, McKee M, Charlesworth K, Wismar M Difficulties of tracing health research funded by the European Union. J Health Serv Res Policy 2010, 15:133-136.
5. Head M, Fitchett JR, Cooke MK, Wurie FB, Hayward AC, Atun R UK investments in global infectious disease research 1997-2010: a case study. Lancet Infect Dis 2012, published online Nov 8. http://dx.doi.org/10.1016/S1473-3099(12)70261-X.
6. Global report for research on infectious diseases of poverty 2012, WHO, World Health Organization on behalf of the Special Programme for Research and Training in Tropical Diseases, Geneva.
7. Van Weel C Translating research into practice-a three-paper series. Lancet 2003, 362:1170.
8. Galsworthy MJ, Hristovski D, Lusa L, et al. Academic output of 9 years of EU investment into health research. Lancet 2012, 380:971-972.
9. Shigayeva A, Atun R, McKee M, Coker R Health systems, communicable diseases and integration. Health Policy Plan 2010, 25(suppl 1):i4-i20.
10. Altice FL, Kamarulzaman A, Soriano VV, Schechter M, Friedland GH. Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. Lancet; 376: 367-87.
11. Deribew A, Tesfaye M, Hailmichael Y, et al. Common mental disorders in TB/HIV co-infected patients in Ethiopia. BMC Infect Dis 2010, 10:201.